Cenra Inc. (TPE:3716)
Taiwan · Delayed Price · Currency is TWD 33.90
-0.60 (-1.74%)
At close: Jul 17, 2026
Cenra Market Cap
Cenra has a market cap or net worth of 4.95 billion as of July 17, 2026. Its market cap has decreased by -4.30% in one year.
Market Cap
4.95B
Enterprise Value
7.14B
Revenue
8.54B
Ranking
n/a
PE Ratio
11.26
Stock Price
33.90
ChartMarket Cap Chart
Since September 2, 2024, Cenra's market cap has decreased from 6.21B to 4.95B, a decrease of -20.16%. That is a compound annual growth rate of -11.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 4.99B | 2.20% |
| Dec 31, 2025 | 4.88B | -12.15% |
| Dec 31, 2024 | 5.56B | -10.42% |
| Sep 2, 2024 | 6.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 492.63B |
| Caliway Biopharmaceuticals | 161.08B |
| Pell Bio-Med Technology | 66.74B |
| Heron Neutron Medical | 65.51B |
| Panion & Bf Biotech | 5.14B |
| Mycenax Biotech | 5.08B |
| UnicoCell Biomed | 4.93B |
| St.Shine Optical | 4.71B |